Glenmark Pharmaceuticals Ltd vs Rajnish Wellness Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Glenmark Pharmaceuticals Ltd is ₹ 2173 as of 12 Jun 15:30 . The P/E Ratio of Glenmark Pharmaceuticals Ltd changed from 13.5 on March 2021 to 41.5 on March 2025 . This represents a CAGR of 25.18% over 5 yearsThe P/E Ratio of Rajnish Wellness Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Glenmark Pharmaceuticals Ltd changed from ₹ 13108 crore on March 2021 to ₹ 43458 crore on March 2025 . This represents a CAGR of 27.09% over 5 yearsThe Market Cap of Rajnish Wellness Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Glenmark Pharmaceuticals Ltd for the Mar '26 is ₹ 3959 crore as compare to the Dec '25 revenue of ₹ 3945 crore. This represent the growth of 0.37% The revenue of Rajnish Wellness Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Glenmark Pharmaceuticals Ltd for the Mar '26 is ₹ 578.28 crore as compare to the Dec '25 ebitda of ₹ 729.88 crore. This represent the decline of -20.77% The ebitda of Rajnish Wellness Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Glenmark Pharmaceuticals Ltd changed from ₹ 340.24 crore to ₹ 301.32 crore over 8 quarters. This represents a CAGR of -5.89% The net profit of Rajnish Wellness Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The Dividend Payout of Glenmark Pharmaceuticals Ltd changed from 4.28 % on March 2021 to 4.38 % on March 2025 . This represents a CAGR of 0.46% over 5 yearsThe Dividend Payout of Rajnish Wellness Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Limited was incorporated on November 18, 1977.
The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity).
It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets.
The Company's research and development facilities are located at Mahape, Sinnar and Taloja and manufacturing facilities are located at Nasik, Colvale, Baddi, Nalagarh, Sikkim, Indore and Aurangabad in India. The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology, Respiratory and Dermatology.
Its branded generics business has a significant presence in markets across emerging economies including India.

About Rajnish Wellness Ltd

Rajnish Wellness Limited was originally incorporated on June 13, 2015 as a Private Limited Company under the name and style of 'Rajnish Hot Deals Private Limited'.
Subsequently, the Company was converted into a Public Limited Company on February 01, 2018 and was renamed to 'Rajnish Wellness Limited' on February 09, 2018. The Company is currently engaged in the business of selling various products in the categories ranging from consumer durables to ayurvedic personal care products.
The Company's major focus area is sexual wellness, energy revitalization and personal care products.
Current product portfolio is concentratedon ayuvedic products. The Company has product portfolio that covers major products including ayurvedic medicines, personal care products, sexual wellness and energy revitalization items etc.

FAQs for the comparison of Glenmark Pharmaceuticals Ltd and Rajnish Wellness Ltd

Which company has a larger market capitalization, Glenmark Pharmaceuticals Ltd or Rajnish Wellness Ltd?

Market cap of Glenmark Pharmaceuticals Ltd is 61,327 Cr while Market cap of Rajnish Wellness Ltd is 44 Cr

What are the key factors driving the stock performance of Glenmark Pharmaceuticals Ltd and Rajnish Wellness Ltd?

The stock performance of Glenmark Pharmaceuticals Ltd and Rajnish Wellness Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Glenmark Pharmaceuticals Ltd and Rajnish Wellness Ltd?

As of June 15, 2026, the Glenmark Pharmaceuticals Ltd stock price is INR ₹2173.2. On the other hand, Rajnish Wellness Ltd stock price is INR ₹0.44.

How do dividend payouts of Glenmark Pharmaceuticals Ltd and Rajnish Wellness Ltd compare?

To compare the dividend payouts of Glenmark Pharmaceuticals Ltd and Rajnish Wellness Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.